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Abstract
Background: Women at increased (genetic) risk of breast cancer have to weigh the personal pros
and cons of prophylactic mastectomy (PM) as an option to reduce their cancer risk. So far, no
routine referral to a psychologist has been investigated for women considering PM. Aim of this
study was to asses: 1) the acceptance of the offer of a standard psychological consultation as part
of pre-surgical decision-making in high-risk women, 2) reasons for PM and reasons for postponing
it, 3) the need for additional psychological interventions, and factors associated, and 4) the
frequency of psychiatric/psychological treatment history.
Methods: During a 30 months period, women at high risk considering PM were offered a
psychological consultation. The content of these, and follow-up, consultations were analyzed.
Results: Most women (70 out of 73) accepted the psychological consultation, and 81% proceeded
with PM. Main reasons for undergoing PM were to reduce anxiety about cancer, and to reduce the
cancer risk. Uncertainty about surgery and the need for further information were the reasons given
most frequently for postponing PM. Additional psychological support was given to 31% before and
14% after PM. The uptake of additional support was significantly higher in women with a BRCA1/2
mutation. A history of psychiatric/psychological treatment was present in 36%, mainly consisting of
depression and grief after death of a mother.
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Hereditary Cancer in Clinical Practice 2009, 7:6 http://www.hccpjournal.com/content/7/1/6Conclusion: The uptake-rate of the standard psychological consultation indicates a high level of
acceptability of this service for women deciding about PM. Since anxiety is one of the main reasons
for considering PM, and depression and grief were present in a third, a standard consultation with
a psychologist for high-risk women considering PM may be indicated. This may help them arrive at
an informed decision, to detect and manage psychological distress, and to plan psychological
support services.
Background
Prophylactic mastectomy (PM) has become a treatment
option for those women identified as being at high risk for
developing breast cancer. Studies on PM consistently
show a risk reduction of breast cancer of at least 90%
[1,2], and in the Netherlands PM is chosen by 35–51% of
healthy women with a BRCA1/2 mutation [3,4].
Since the decision to pursue PM is complex, personal, and
ultimately irreversible, it has been suggested that decision-
making should include counseling of the woman by a
multidisciplinary team of specialists, addressing the bene-
fits of the different procedures as well as the surgical and
psychological risks of PM [5]. The information perceived
by women as being most important with respect to the
decision for risk-reductive surgery was a BRCA test result
and discussion of the family cancer history, whereas rea-
sons for persisting indecision about surgery included
genetic test results, concerns about surgery as a procedure,
and timing in life [6].
Women who elected to undergo PM reported experienc-
ing higher levels of anxiety associated with developing
breast cancer than those women who did not opt for sur-
gery [7]. Studies have shown that the majority of women
following PM reported decreased (hereditary) cancer
related distress while other psychosocial functioning does
not appear to be significantly affected in a negative way
[5,8-10]. Post-surgical distress appeared to be related to
surgical complications, perceived risk of breast cancer,
having young children, and psychiatric history [11-14].
Such factors as they relate to distress in women warrant
additional attention, and several authors have recom-
mended to (further) identify women at psychological risk
in order to provide the appropriate psychological or psy-
chiatric care [14,15]. While there are high levels of
endorsement for the provision of psychological consulta-
tion before and after PM by women considering surgery,
and pre-surgical psychological consultation is available in
some centers, it is by no means a routine, integrated com-
ponent of the pre- or post-surgical care of women who
undergo PM in most settings [16].
As of the start of the Rotterdam Family Cancer Clinic in
1991 prophylactic surgery was discussed with either
healthy women (unaffected) or women with a history of
breast or ovarian cancer (affected) after exclusion of recur-
rent disease by standard dissemination examinations. The
counseling sessions, the surveillance programs and/or
(preventive) interventions for BRCA1/2 mutation carriers
and for women at increased risk of hereditary breast/ovar-
ian cancer, were carried out by a multidisciplinary team of
medical, surgical, and gynecological oncologists, in col-
laboration with clinical geneticists. Apart from separate
information sessions for the high-risk women with the
different specialists of the family cancer clinic team, each
case was discussed separately and consensus regarding
policy was sought at the scheduled multidisciplinary
meetings. This approach was formalized in a written pro-
tocol, and approved by the working party on hereditary
tumors of our institution. Institutional guidelines became
available as of 1995, and were regularly updated.
Because optimal counseling in the process of decision-
making regarding PM was considered important and few
data were available at that time, the committee on hered-
itary tumors at our institution decided that, as of 1999,
referral to a psychologist would be standard procedure
before PM. Aim of this study was to asses: 1) the accept-
ance of the offer of a standard psychological consultation
as part of pre-surgical decision-making in high-risk
women, 2) reasons for PM and reasons for postponing it,
3) the need for additional psychological interventions,
and factors associated, and 4) the frequency of psychiat-
ric/psychological treatment history in these high risk
women.
Methods and participants
Psychosocial Oncology Service
The psychologist is a member of the Department of Psy-
chosocial Oncology, a multidisciplinary liaison Psychoso-
cial Oncology Care Service since 1987, where 2
psychiatrists, 1 psychologist, 1 psychiatric nurse specialist,
5 social workers, and 2 chaplains, work in close collabo-
ration with the medical specialists and nursing staff in the
management of cancer patients. Psychiatric medications,
psychological interventions, advice, spiritual counseling
and educational support can be tailored to address spe-
cific needs of cancer patients and their families. In provid-
ing a standard psychological consultation pre-surgery we
hoped to better understand the psychological issues facedPage 2 of 7
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ing and their need for (additional) psychological support.
Study population
Between June 1999 and December 2001, 73 women at
risk of developing hereditary breast cancer who were con-
sidering PM, were routinely referred to the psychologist
(M.T.). Criteria for referral to the psychologist were: a high
risk of developing breast cancer (either being a carrier of a
BRCA1/2 mutation, or being at 50% risk for being a car-
rier, with or without a history of breast/ovarian cancer,
and without disease recurrence), and interest in PM as an
option to reduce the breast cancer risk. Partners were also
actively encouraged to attend the psychological consulta-
tion.
Psychological consultation
The consultation was performed in a standardized man-
ner. Beforehand, information on demographics and med-
ical history were obtained from the hospital medical
record, and the consultation started with verifying this
information. Questions were posed about the woman's
reaction to the genetic testing result, and the impact of this
result for herself, her partner and her family. The women
were also asked to discuss their personal experience with
cancer (or within their family) and their associated fears.
Then, the woman's motivations and reasons to undergo
PM, and the assumed consequences of the PM regarding
sexuality, were addressed by means of the following ques-
tions: "Can you tell me why you are considering prophylactic
mastectomy at this moment? Have you (both) spoken about the
consequences of the surgery for your sexual life and, if so, can
you tell me about that?" Moreover, we asked about any
issues concerning the hospital admission, and their sup-
port system, using the following question: "Is there any-
thing we have to do, or can do, to support you during your stay
in the hospital?" Finally, we asked if there was any personal
history of psychological/psychiatric treatment and, if so,
what were the reason(s) for this, and how was this treated.
At the end of the consultation (lasting about one hour),
according to the expert rating, the psychologist and the
counselee decided whether psychological support was
needed or was considered helpful. Additional psycholog-
ical help was supportive orientated and existed of individ-
ual psychological interventions and counseling for the
women and their partners. In case of (continuing) need
for psychotropic medication, antidepressant medication,
this was administered by the liaison psychiatrist. Psycho-
logical support started either after the consultation, dur-
ing, and/or after the hospital admission for the PM, and
was always proposed actively in case of current mental
problems and/or burdensome psychosocial circum-
stances. In case of relevant mental problems, such as
mood disorders and anxiety disorders (based on DSM-IV
criteria [17]), the PM was postponed. A summary of the
psychological consultation was made and sent to the phy-
sicians involved and also, on request, to the counselees.
Specific concerns, i.e. present mental illness, ongoing
uncertainty about the decision to undergo PM, or when
extra decisional counseling sessions were considered nec-
essary, were communicated by the psychologist at the
scheduled multidisciplinary meetings.
Data collection and statistical analysis
Data abstracted from the medical file included: age,
genetic risk status, cancer status, cancer site, and family
cancer history. Using a self-developed checklist, the fol-
lowing variables were obtained from the psychological
consultation: primary reasons for opting or declining sur-
gery, current psychological distress, need for additional
psychological support, and previous psychological/psy-
chiatric treatment. In cases of new psychological consulta-
tions over time reasons for referral and relevant problems
as stated by the referring doctor were collected.
Differences between women with and without additional
psychological support, respectively, were tested by a t-test
(for continuous variables) or a Chi-square test (for cate-
gorical variables). A p-value less than 0.05 was considered
statistically significant. All analyses were performed with
STATA SE software (version 9).
Results
Participants
In total, 70 of the 73 women (96%) who were routinely
referred to the psychologist before PM were interviewed.
Three women declined the psychological consultation,
despite receiving a second invitation by letter; two of these
three women proceeded with the surgery. The median
period between the consultation and the follow-up for
this analysis was 26 (range 24–50) months. Of the 70
interviewed women, 57 (81%) proceeded with PM, while
13 (19%) reconsidered or postponed the decision with
respect to PM within the range of the follow-up period.
Additional file 1, Table S1 presents the characteristics of
the total group of 70 interviewed women. The study sam-
ple consisted mainly of unaffected women, and BRCA1/2
mutation carriers (n = 52; 74%). Unaffected women con-
sidering PM were significantly younger than affected
women (38 vs 48 years; p = 0.002). Of the 18 women
without a confirmed mutation, 8 (44%) had been treated
for breast cancer (See Additional file 1, Table S1).
Motivating factors for proceeding with or declining PM
The motivating factors mentioned by the women opting
for PM are shown in Additional file 1, Table S2. Reduction
of the anxiety for, and the risk of cancer; attempting to
break the vicious circle of developing cancer and/or dyingPage 3 of 7
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ily, spouse and children, were the three most prominent
reasons for PM. The reasons for declining or postponing
PM were known for all 13 women (Additional file 1, Table
S3) and mostly included: uncertainty to proceed with sur-
gery because they needed more time and information to
make a final decision, and the need for a better under-
standing of the risk estimation (See Additional file 1,
Table S2 and Table S3).
Extra psychological support
Of the interviewed women, 22 (31%) received additional
psychological help by the same psychologist who inter-
viewed them. Six women (27%) had 1–2 extra counseling
sessions before the hospital admission for PM to help
them cope with the upcoming surgery. Fourteen women
(64%) were visited 1–3 times during their admission in
the hospital for PM. Ten women (14%) received addi-
tional psychological support after PM. Major depression
was diagnosed in 3 women (30%) following PM and all
received antidepressant medication, 1 woman had her
first major depressive episode, 2 women had a recurrence
of depression at this time. Four women received psycho-
logical support for adjustment problems after surgery
(40%), and 3 women (30%) received further bereavement
counseling. Eventually, 4 of these 10 (40%) women were
referred to an outpatient Mental Health provision for fur-
ther support. Figure 1 shows a flow chart of support over
time (see Figure 1).
Of the 13 women who reconsidered or postponed their
decision for PM, 3 (23%) received extra psychological
support with a total amount of 19 interventions within 1
year. One woman was too anxious to come to the hospital
and unable to go through with the prophylactic surgery.
Another woman (who was treated for breast cancer 1.5
years before considering PM) realized that she needed
extra information with respect to risk estimation. Finally,
insurance problems with respect to breast reconstruction
emerged for one woman who later decided to undergo
breast reconstruction in another country.
Additional file 1, Table S4 presents the characteristics of
the women who were (n = 22), or were not receiving addi-
tional psychological support (n = 48). Of the 22 women
receiving extra support, 10 (45%) had a history of psychi-
atric/psychological treatment, versus 15 of the 48 women
(31%) not requiring additional psychological support (p
= 0.25). The uptake for additional psychological support
was significantly higher in women with a proven BRCA1
or BRCA2 mutation (91% vs 67%; p = 0.03), and tended
to be higher in women with experience of death due to
cancer of a sister (23% vs 2%; p = 0.07). Of the 57 women
who proceeded with PM, 19 (33%) received extra psycho-
logical support. Cancer status and whether or not pro-
ceeding with PM did not differ between women receiving
or not receiving extra psychological support (see Addi-
tional file 1, Table S4).
Reported history of psychiatric/psychological treatment
Of the interviewed women, 25 (36%) reported a history
of psychiatric/psychological treatment and had all been
treated by health professionals at an out-patient Mental
Health provision in The Netherlands. Thirteen women
(52%) were treated for affective disorders, (recurrent)
depressions, for which they received antidepressant med-
ication psychotherapy. Six women (24%) had been
treated for stress related disorders: 1 after a suicide
attempt, 2 after a divorce, 2 after burn out, and 1 relating
to the diagnosis of cancer. Six women (24%) were referred
for psychotherapeutic interventions by their GP because
of bereavement due to death of a mother.
Discussion and conclusion
Discussion
This long-term study assessed the acceptance of the offer
of a psychological consultation as standard practice pre-
surgical, primary reasons in (genetically) high-risk
Figure 1
High risk women considering PM who were standard reffered to a 
psychologist
                                                     N=73 
Contact with psychologist 
before PM 
                        N=70 
Additional support from 
psychologist before PM 
             N=22 (31%) 
No Prophylactic Mastectomy (PM)
N=13 (19%) 
Prophylactic Mastectomy (PM)
            N=57 (81%) 
Additional support from 
psychologist after PM
N=10 (14%) 
Additional support from 
psychologist
N=3 (23%) 
No contact with psychologist 
N=3
N=1
N=2Page 4 of 7
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tectomy, the need for additional support, and reported
data on a psychiatric/psychological treatment history. Our
study sample was relatively large, including 70 high-risk
women from a single-center family cancer clinic. The most
important findings of our analysis are: 1) 70 out of 73
women accepted the psychological consultation as stand-
ard practice pre-surgery; 2) main reasvons to undergo PM
were to reduce anxiety for and the risk of developing can-
cer, and to avoid repetition of the family cancer history,
19% of the interviewed women reconsidered or post-
poned the PM because of 'uncertainty about the decision'
and 'a need for more risk information'; 3) 31% of the
women received additional psychological support; and 4)
36% of the women considering PM reported a history of
psychiatric/psychological treatment.
In the present study, the two main reasons for women to
opt for PM were: to reduce anxiety for and the risk of
developing cancer, and to avoid a repetition of the family
cancer history. The two most important reasons to decline
or postpone PM were: uncertainty to proceed with sur-
gery, and the need for a better understanding of the risk
estimation. These results are consistent with the findings
of others [9,18,19], and indicate that the information pro-
vided at the family cancer clinic is complex, thus stressing
the importance of repetitive but consistent information
regarding the cancer risk by the different clinicians
involved. Referral to the psychologist is relevant in this
respect to help explore the quality of decision-making,
and to determine which additional information is needed
to help women make an optimal informed decision.
In our study sample, 1 in 3 women opting for and pro-
ceeding with PM received extra psychological support; 10
women continued to receive additional psychological
support after surgery, and 3 of them required antidepres-
sants. The latter finding is in accordance with Hopwood et
al. [20], who reported that 16% (7/45) of their group
required further psychiatric help following PM, and anti-
depressant medication was used by 3 women. In our study
sample, the most important factors associated with addi-
tional psychological support were genetic risk status, and
the experience with cancer in a close relative. Although,
our small study subgroups do not allow more detailed sta-
tistical analyses, the latter findings are supported by
Erblich et al. [21] who found the highest distress scores
among women whose mother had died from breast can-
cer and who had been involved in the care of their mother
during the cancer process. Similarly, Van Dooren et al.
[22] found that having a sister with breast cancer and
being involved in her disease process was more distressing
to women than having experienced the process of breast
cancer in a mother. Thus, focusing on this issue in the care
of, and in future studies on, high-risk women, is war-
ranted.
The high frequency (36%) of history of psychiatric/psy-
chological treatment (mainly for depressions and
bereavement) in high-risk women opting for PM might
reflect the emotional distress associated with the process
of sickness and death due to cancer in family relatives.
This is in accordance with Wellish et al. who reported that
psychological distress was more pronounced in daughters
with a mother affected with breast cancer during adoles-
cence as compared to during adulthood [23]. Similarly,
Hopwood et al. found that women bereaved of their
mothers due to cancer during adolescence had higher can-
cer worries than women who had lost their mothers dur-
ing adulthood [24].
To our knowledge, no other data on the rate of psychiat-
ric/psychological treatment history in women opting for
PM are available with which to compare our results.
According to the National Mental Health Survey and Inci-
dence (NEMESIS) the lifetime observed prevalence rate
for psychiatric disorder for women in the Netherlands is
40% [25]. However, as this is a lifetime prevalence in the
Dutch female population aged 18 to 64 years, this is not
directly comparable with our population. The high rates
of psychiatric/psychological treatment history in women
opting for PM warrant further research in larger groups,
and such research should also include high-risk women
opting for intensive surveillance.
Limitations
Between June 1999 and December 2001, 87 women at
increased risk of hereditary breast cancer underwent PM at
our clinic. Of these 71% (n = 59) were referred for a psy-
chological consultation. It is most plausible that both
logistical problems at the start of this study (the fact that
it needed some time to get all the medical specialists in
line to routinely refer these women pre-surgery to the psy-
chologist) and patient characteristics (e.g., more vulnera-
ble women were referred) have played a role in the
suboptimal referral rate. The observation that the number
of unaffected women significantly exceeded that of the
affected women, whereas the number of women having
undergone PM at our institution consists of about 50%
affected women [26], supports the idea that selection bias
for referral to the psychologist has indeed occurred. It is
therefore unclear to what extent our results may be an
overestimation of the percentage in need for additional
psychological interventions. Another limitation is the lack
of a comparison group of mutation carriers who were not
considering PM.
Conclusion
Our results indicate that genetically susceptible women
considering PM are vulnerable, especially mutation carri-
ers and those having been involved in the cancer process
and death of a close relative. This should be explored
more extensively in future, prospective, studies in order toPage 5 of 7
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consultation with the psychologist for high-risk women
considering a PM is indicated, in order to help them come
to an informed decision, to detect and manage psycholog-
ical distress, and to plan psychological support services
accordingly.
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